Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo Bastida

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
JMIR Research Protocols|December 23, 2018
A Web-Based Telemanagement System for Patients With Complex Inflammatory Bowel Disease: Protocol for a Randomized Controlled Clinical TrialMariam Aguas, Javier Del Hoyo, Raquel Faubel, et al.
World Journal of Gastroenterology|October 17, 2014
Small intestinal bacterial overgrowth in inactive Crohn's disease: influence of thiopurine and biological treatmentCristina Sánchez-Montes, Vicente Ortiz, Guillermo Bastida, et al.
Gastroenterologia Y Hepatologia|December 10, 2023
Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprineGuillermo Bastida, Diego Alvarez-Sotomayor, Mariam Aguas, et al.
Journal of Clinical Apheresis|May 10, 2017
Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokinesBelén Beltrán, Esteban Sáez-González, Inés Moret, et al.
Nutrients|June 2, 2021
Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron TreatmentGuillermo Bastida, Claudia Herrera-de Guise, Alicia Algaba, et al.
Gastroenterologia Y Hepatologia|January 22, 2022
The characteristics of the stricture, but not the ongoing treatment, could influence the outcome of endoscopic dilation in recurrent Crohn's diseasePablo Ladrón Abia, Noelia Alonso, Alejandro Mínguez Sabater, et al.
International Journal of Environmental Research and Public Health|March 19, 2020
Adaptation of TECCU App Based on Patients´ Perceptions for the Telemonitoring of Inflammatory Bowel Disease: A Qualitative Study Using Focus GroupsJavier Del Del Hoyo, Pilar Nos, Raquel Faubel, et al.
Digestive Diseases (Basel, Switzerland)|August 28, 2018
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's DiseaseBelén Beltrán, Marisa Iborra, Esteban Sáez-González, et al.
Inflammatory Bowel Diseases|July 15, 2017
Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical PracticeMariam Aguas Peris, Virginia Bosó, Belén Navarro, et al.
Gastroenterologia Y Hepatologia|September 13, 2024
Optimizing outcomes with maintenance IV UST in highly bio-exposed patients with IBD. Efficacy and adjusted regimen in real worldAlejandro Mínguez, Elena Coello, Alejandro Garrido, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
JMIR Research Protocols|December 23, 2018
A Web-Based Telemanagement System for Patients With Complex Inflammatory Bowel Disease: Protocol for a Randomized Controlled Clinical TrialMariam Aguas, Javier Del Hoyo, Raquel Faubel, et al.
World Journal of Gastroenterology|October 17, 2014
Small intestinal bacterial overgrowth in inactive Crohn's disease: influence of thiopurine and biological treatmentCristina Sánchez-Montes, Vicente Ortiz, Guillermo Bastida, et al.
Gastroenterologia Y Hepatologia|December 10, 2023
Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprineGuillermo Bastida, Diego Alvarez-Sotomayor, Mariam Aguas, et al.
Journal of Clinical Apheresis|May 10, 2017
Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokinesBelén Beltrán, Esteban Sáez-González, Inés Moret, et al.
Nutrients|June 2, 2021
Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron TreatmentGuillermo Bastida, Claudia Herrera-de Guise, Alicia Algaba, et al.
Gastroenterologia Y Hepatologia|January 22, 2022
The characteristics of the stricture, but not the ongoing treatment, could influence the outcome of endoscopic dilation in recurrent Crohn's diseasePablo Ladrón Abia, Noelia Alonso, Alejandro Mínguez Sabater, et al.
International Journal of Environmental Research and Public Health|March 19, 2020
Adaptation of TECCU App Based on Patients´ Perceptions for the Telemonitoring of Inflammatory Bowel Disease: A Qualitative Study Using Focus GroupsJavier Del Del Hoyo, Pilar Nos, Raquel Faubel, et al.
Digestive Diseases (Basel, Switzerland)|August 28, 2018
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's DiseaseBelén Beltrán, Marisa Iborra, Esteban Sáez-González, et al.
Inflammatory Bowel Diseases|July 15, 2017
Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical PracticeMariam Aguas Peris, Virginia Bosó, Belén Navarro, et al.
Gastroenterologia Y Hepatologia|September 13, 2024
Optimizing outcomes with maintenance IV UST in highly bio-exposed patients with IBD. Efficacy and adjusted regimen in real worldAlejandro Mínguez, Elena Coello, Alejandro Garrido, et al.
Pageof 6